Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics
Article Sidebar
Main Article Content
Abstract
Background: The primary hurdle to curing HIV is due to the establishment of a reservoir early in infection. In an effort to find new treatment strategies, we and others have focused on understanding the selection pressures exerted on the reservoir by studying how proviral sequences change over time.
Methods: To gain insights into the dynamics of the HIV reservoir we analyzed longitudinal near full-length sequences from 7 people living with HIV between 1 and 20 years following the initiation of antiretroviral treatment. We used this data to employ Bayesian mixed effects models to characterize the decay of the reservoir using single-phase and multiphasic decay models based on near full-length sequencing. In addition, we developed a machine-learning approach utilizing logistic regression to identify elements within the HIV genome most associated with proviral decay and persistence. By systematically analyzing proviruses that are deleted for a specific element, we gain insights into their role in reservoir contraction and expansion.
Results: Our analyses indicate that biphasic decay models of intact reservoir dynamics were better than single-phase models with a stronger statistical fit. Based on the biphasic decay pattern of the intact reservoir, we estimated the half-lives of the first and second phases of decay to be 18.2 (17.3 to 19.2, 95%CI) and 433 (227 to 6400, 95%CI) months, respectively.
In contrast, the dynamics of defective proviruses differed favoring neither model definitively, with an estimated half-life of 87.3 (78.1 to 98.8, 95% CI) months during the first phase of the biphasic model. Machine-learning analysis of HIV genomes at the nucleotide level revealed that the presence of the splice donor site D1 was the principal genomic element associated with contraction. This role of D1 was then validated in an in vitro system. Using the same approach, we additionally found supporting evidence that HIV nef may confer a protective advantage for latently infected T cells while tat was associated with clonal expansion.
Conclusions: The nature of intact reservoir decay suggests that the long-lived HIV reservoir contains at least 2 distinct compartments. The first compartment decays faster than the second compartment. Our machine-learning analysis of HIV proviral sequences reveals specific genomic elements are associated with contraction while others are associated with persistence and expansion. Together, these opposing forces shape the reservoir over time.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Trickey A, Sabin CA, Burkholder G, Crane H, d'Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, Lampe FC, Obel N, Reyes JM, Stephan C, Sterling TR, Teira R, Touloumi G, Wasmuth JC, Wit F, Wittkop L, Zangerle R, Silverberg MJ, Justice A, Sterne JAC. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. The Lancet HIV. 2023;10(5):e295-e307. doi: 10.1016/S2352-3018(23)00028-0. Epub 2023 Mar 20. PMID: 36958365; PMCID: PMC10288029.
2. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295-1300. doi: 10.1126/science.278.5341.1295. PMID: 9360927.
3. Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science.1997;278(5341):1291-1295. doi: 10.1126/science.278.5341.1291. PMID: 9360926.
4. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387(6629):183-188. doi: 10.1038/387183a0. PMID: 9144289.
5. Laskey SB, Pohlmeyer CW, Bruner KM, Siliciano RF. Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality. PLoS Pathogens. 2016;12(8):1-17. doi: 10.1371/journal.ppat.1005689. PMID: 27494508; PMCID: PMC4975415.
6. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+T cells. Nat Med. 2003;9(6):727-8. doi: 10.1038/nm880. Epub 2003 May 18. PMID: 12754504.
7. Finzi D, Siliciano RF. Viral dynamics in HIV-1 infection. Cell. 1998;93(5):665-71. doi: 10.1016/s0092-8674(00)81427-0. PMID: 9630210.
8. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC, Kempf DJ, Mellors JW, Coffin JM, King MS. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A. 2008;105(10):3879-84. doi: 10.1073/pnas.0800050105. Epub 2008 Mar 10. PMID: 18332425; PMCID: PMC2268833.
9. De Boer RJ, Perelson AS. Target cell limited and immune control models of HIV infection: A comparison. J Theor Biol. 1998;190(3):201-14. doi: 10.1006/jtbi.1997.0548. PMID: 9514649.
10. Palmer S, Josefsson L, Coffin JM, editors. HIV reservoirs and the possibility of a cure for HIV infection. J Intern Med. 2011 Dec;270(6):550-60. doi: 10.1111/j.1365-2796.2011.02457.x. Epub 2011 Oct 27. PMID: 21929712.
11. McMyn NF, Varriale J, Fray EJ, Zitzmann C, MacLeod H, Lai J, Singhal A, Moskovljevic M, Garcia MA, Lopez BM, Hariharan V, Rhodehouse K, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. J Clin Invest. 2023;133(17):e171554. doi: 10.1172/JCI171554. PMID: 37463049; PMCID: PMC10471168.
12. Peluso MJ, Bacchetti P, Ritter KD, Beg S, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy. JCI Insight. 2020;5(4):e132997. doi: 10.1172/jci.insight.132997. PMID: 32045386; PMCID: PMC7101154.
13. Gandhi M, Hickey M, Imbert E, Grochowski J, Mayorga-Munoz F, Szumowski JD, Oskarsson J, Shiels M, Sauceda J, Salazar J, Dilworth S, Nguyen JQ, Glidden DV, Havlir DV, Christopoulos KA. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV. Ann Intern Med. 2023;176(7):969-974. doi: 10.7326/M23-0788. PMID: 37399555; PMCID: PMC10771861.
14. Pinzone MR, VanBelzen DJ, Weissman S, Bertuccio MP, Cannon LM, Venanzi-Rullo E, Migueles S, Jones RB, Mota T, Joseph SB, Groen K, Pasternak AO, Hwang WT, Sherman B, Vourekas A, Nunnari G, O’Doherty U. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nat Comm. 2019;10(1):728. doi: 10.1038/s41467-019-08431-7. PMID: 30760706; PMCID: PMC6374386.
15. Rullo EV, Pinzone MR, Cannon LM, Weissman S, Ceccarelli M, Zurakowski R, Nunnari G, O’Doherty U. Persistence of an intact HIV reservoir in phenotypically naive T cells. JCI Insight. 2020;5(20):e133157. doi: 10.1172/jci.insight.133157. PMID: 33055422; PMCID: PMC7605525.
16. Cho A, Gaebler C, Olveira T, Ramos V, Saad M, Lorenzi JCC, Gazumyan A, Moir S, Caskey M, Chun TW, Nussenzweig MC. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing. Proc Natl Acad Sci U S A. 2022;119(4):e2117630119. doi: 10.1073/pnas.2117630119. PMID: 35042816; PMCID: PMC8794825.
17. Simonetti FR, Zhang H, Soroosh GP, Duan J, Rhodehouse K, Hill AL, Beg SA, McClurkan K, Raymond HE, Nobles CL, Everett JK, Kwon KJ, White JA, Lai J, Margolick JB, Hoh R, Deeks SG, Bushman FD, Siliciano JD, Siliciano RF. Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+T cells in vivo. J Clin Invest. 2021;131(3):e145254. doi: 10.1172/JCI145254. PMID: 33301425; PMCID: PMC7843227.
18. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM, Schacker TW, Hill BJ, Douek DC, Routy JP, Haddad EK, Sékaly RP. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893-900. doi: 10.1038/nm.1972. PMID: 19543283; PMCID: PMC2859814.
19. Besson GJ, Lalama CM, Bosch RJ, Gandhi RT, Bedison MA, Aga E, Riddler SA, McMahon DK, Hong F, Mellors JW. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clin Infect Dis. 2014;59(9):1312-21. doi: 10.1093/cid/ciu585. PMID: 25073894; PMCID: PMC4200019.
20. Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M, Brubaker MA, Guo J, Li P, Riddell A. Stan: A probabilistic programming language. J Stat Softw. 2017;76:1. doi: 10.18637/jss.v076.i01. PMID: 36568334; PMCID: PMC9788645.
21. Vehtari A, Gelman A, Gabry J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat Comput. 2017; 27:1413–1432. doi: 10.1007/s11222-016-9696-4.
22. Gronau QF, Singmann H, Wagenmakers EJ. Bridgesampling: An R package for estimating normalizing constants. J Stat Softw. 2020; 92(10): 1–29. doi: 10.18637/jss.v092.i10.
23. Bürkner PC. brms: An R package for Bayesian multilevel models using Stan. J Stat Softw. 2017; 80(1)1–28. doi: 10.18637/jss.v080.i01.
24. Martin Stoltzfus C. Chapter 1 Regulation of HIV-1 Alternative RNA Splicing and Its Role in Virus Replication. 1 ed: Elsevier Inc.; 2009;74:1-40. doi: 10.1016/S0065-3527(09)74001-1. PMID: 19698894.
25. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993;67(11):6365-78. doi: 10.1128/jvi.67.11.6365-6378.1993. PMID: 8411338; PMCID: PMC238071.
26. Liu R, Simonetti FR, Ho YC. The forces driving clonal expansion of the HIV-1 latent reservoir.Virol J. 2020;17(1):4. doi: 10.1186/s12985-019-1276-8. PMID: 31910871; PMCID: PMC6947923.
27. Simonetti FR, Sobolewski MD, Fyne E, Shao W, Spindler J, Hattori J, Anderson EM, Watters SA, Hill S, Wu X, Wells D, Su L, Luke BT, Halvas EK, Besson G, Penrose KJ, Yang Z, Kwan RW, Van Waes C, Uldrick T, Citrin DE, Kovacs J, Polis MA, Rehm CA, Gorelick R, Piatak M, Keele BF, Kearney MF, Coffin JM, Hughes SH, Mellors JW, Maldarelli F. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc Natl Acad Sci U S A. 2016;113(7):1883-8. doi: 10.1073/pnas.1522675113. PMID: 26858442; PMCID: PMC4763755.
28. Wang Z, Gurule EE, Brennan TP, Gerold JM, Kwon KJ, Hosmane NN, Kumar MR, Beg SA, Capoferri AA, Ray SC, Ho Y-C, Hill AL, Siliciano JD, Siliciano RF. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.Proc Natl Acad Sci U S A. 2018;115(11):E2575-E2584. . doi: 10.1073/pnas.1720665115. PMID: 29483265; PMCID: PMC5856552.
29. Hill AL, Rosenbloom DIS, Nowak MA, Siliciano RF. Insight into treatment of HIV infection from viral dynamics models. Immunol Rev. 2018;285(1):9-25. doi: 10.1111/imr.12698. PMID: 30129208; PMCID: PMC6155466.
30. Trinité B, Ohlson EC, Voznesensky I, Rana SP, Chan CN, Mahajan S, Alster J, Burke SA, Wodarz D, Levy DN. An HIV-1 Replication Pathway Utilizing Reverse Transcription Products That Fail To Integrate. J Virol. 2013;87(23):12701-20. doi: 10.1128/jvi.01939-13. PMID: 24049167; PMCID: PMC3838139..
31. White JA, Wu F, Yasin S, Moskovljevic M, Varriale J, Dragoni F, Contreras AC, Duan J, Zheng MY, Tadzong NF, others. Clonally expanded HIV-1 proviruses with 5’-Leader defects can give rise to nonsuppressible residual viremia. J Clin Invest. 2023;133(6):e165245. doi: 10.1172/JCI165245. PMID: 36602866; PMCID: PMC10014112.
32. Lu X, Heimer J, Rekosh D, Hammarskjold ML. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.Proc Natl Acad Sci U S A. 1990;87(19):7598-602. doi: 10.1073/pnas.87.19.7598. PMID: 2217190; PMCID: PMC54795.
33. Gandhi RT, Cyktor JC, Bosch RJ, Mar H, Laird GM, Martin A, Collier AC, Riddler SA, Macatangay BJ, Rinaldo CR, Eron JJ, Siliciano JD, McMahon DK, Mellors JW, Hogg E, Leblanc R, Scello C, Palm D, Gandhi M, Fletcher C, Podany A, Aweeka F, Halvas L, Dragavon J, Joseph J, Lagattuta R, Lin L, Pederson S, Robertson K, Rubin L, Smith D, Spudich S, Tsibris A. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy. J Infect Dis. 2021;223(2):225-233. doi: 10.1093/infdis/jiaa532. PMID: 32823274; PMCID: PMC7857155.
34. Antar AAR, Jenike KM, Jang S, Rigau DN, Reeves DB, Hoh R, Krone MR, Keruly JC, Moore RD, Schiffer JT, Nonyane BAS, Hecht FM, Deeks SG, Siliciano JD, Ho YC, Siliciano RF. Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. J Clin Invest. 2020;130(7):3543-3559. doi: 10.1172/JCI135953. PMID: 32191639; PMCID: PMC7324206.
35. Luo R, Piovoso MJ, Martinez-Picado J, Zurakowski R. HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics. PLoS ONE. 2012;7(7):e40198. doi: 10.1371/journal.pone.0040198. PMID: 22815727; PMCID: PMC3397989.
36. Hiener B, Horsburgh BA, Eden JS, Barton K, Schlub TE, Lee E, von Stockenstrom S, Odevall L, Milush JM, Liegler T, Sinclair E, Hoh R, Boritz EA, Douek D, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+T Cells from Effectively Treated Participants.Cell Rep. 2017;21(3):813-822. doi: 10.1016/j.celrep.2017.09.081. PMID: 29045846; PMCID: PMC5960642.
37. Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nat Comm. 2018;9(1):4811. doi: 10.1038/s41467-018-06843-5. PMID: 30446650; PMCID: PMC6240116.
38. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS ONE.2009;4(8):e6687. doi: 10.1371/journal.pone.0006687. PMID: 19690614; PMCID: PMC2723923.
39. Duette G, Hiener B, Morgan H, Mazur FG, Mathivanan V, Horsburgh BA, Fisher K, Tong O, Lee E, Ahn H, Shaik A, Fromentin R, Hoh R, Bacchus-Souffan C, Nasr N, Cunningham AL, Hunt PW, Chomont N, Turville SG, Deeks SG, Kelleher AD, Schlub TE, Palmer S. The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells. J Clin Invest. 2022;132(7):e154422. doi: 10.1172/JCI154422. PMID: 35133986; PMCID: PMC8970682.
40. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE. HIV-1 nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol. 2002;13(7):1806-15. doi: 10.1097/01.ASN.0000019642.55998.69. PMID: 12089376.
41. Kmiec D, Srinivasachar S, Kirchhoff F. Potential roles of Nef and Vpu in HIV-1 latency. Future Virology. 2019;14(4). doi: 10.2217/fvl-2018-0214.
42. Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA. Impaired Nef Function Is Associated with Early Control of HIV-1 Viremia. J Virol. 2014;88(17):10200-13. doi: 10.1128/jvi.01334-14. PMID: 24965469; PMCID: PMC4136354.
43. Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, Miller RL, Rahimi A, Laeyendecker O, Bonner P, Yue FY, Benko E, Kovacs CM, Brockman MA, Ostrowski M, Brumme ZL. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals. J Virol. 2019;93(6):e01832-18. doi: 10.1128/jvi.01832-18. PMID: 30602611; PMCID: PMC6401425.
44. Pham TNQ, Lukhele S, Hajjar F, Routy JP, Cohen ÉA. HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. Retrovirology. 2014 Feb 6;11:15. doi: 10.1186/1742-4690-11-15. PMID: 24498878; PMCID: PMC3930549.
45. Quaranta MG, Camponeschi B, Straface E, Malorni W, Viora M. Induction of interleukin-15 production by HIV-1 Nef protein: A role in the proliferation of uninfected cells. Exp Cell Res. 1999;250(1);250(1):112-21. doi: 10.1006/excr.1999.4494. PMID: 10388525.
46. Geleziunas R, Bour S, Wainberg MA. Cell surface down‐modulation of CD4 after infection by HIV‐1.FASEB J. 1994;8(9):593-600. doi: 10.1096/fasebj.8.9.8005387. PMID: 8005387.
47. Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC. Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis. J Virol. 2003;77(3):2124-33. doi: 10.1128/jvi.77.3.2124-2133.2003. PMID: 12525647; PMCID: PMC140869.
48. Arora VK, Fredericksen BL, Garcia JV. Nef: Agent of cell subversion. Microbes Infect. 2002 Feb;4(2):189-99. doi: 10.1016/s1286-4579(01)01527-1. PMID: 11880052.
49. Roeth JF, Kasper MR, Filzen TM, Collins KL. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol. 2004;167(5):903-13. doi: 10.1083/jcb.200407031. PMID: 15569716; PMCID: PMC2172469.
50. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression.Proc Natl Acad Sci U S A. 2001;98(21):12144-9. doi: 10.1073/pnas.221256498. PMID: 11593029; PMCID: PMC59782.
51. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, D'Aloja P, Schürmann A, Baur AS. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent bad-phosphorylation to induce anti-apoptotic signals. Nat Med. 2001;7(11):1217-24. doi: 10.1038/nm1101-1217. PMID: 11689886.
52. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature. 2001;410(6830):834-8. doi: 10.1038/35071111. PMID: 11298454.
53. Jablonski JA, Amelio AL, Giacca M, Caputi M. The transcriptional transactivator Tat selectively regulates viral splicing. Nucleic Acids Res. 2009;38(4):1249-60. doi: 10.1093/nar/gkp1105. PMID: 19966273; PMCID: PMC2831323.
54. Kamori D, Ueno T. HIV-1 tat and viral latency: What we can learn from naturally occurring sequence variations. Front Microbiol. 2017 Jan 30;8:80. doi: 10.3389/fmicb.2017.00080. PMID: 28194140; PMCID: PMC5276809.
55. Pugliese A, Vidotto V, Beltramo T, Petrini S, Torre D. A review of HIV-1 Tat protein biological effects. Cell Biochem Funct. 2005 Jul-Aug;23(4):223-7. doi: 10.1002/cbf.1147. PMID: 15473004.
56. Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: The versatile protein of human immunodeficiency virus type 1. J Gen Virol. 2010 Jan;91(Pt 1):1-12. doi: 10.1099/vir.0.016303-0. Epub 2009 Oct 7. PMID: 19812265.
57. Yeh YHJ, Jenike KM, Calvi RM, Chiarella J, Hoh R, Deeks SG, Ho YC. Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation. J Clin Invest. 2020;130(9):4969-4984. doi: 10.1172/JCI137371. PMID: 32573496; PMCID: PMC7456222.
58. Cesana D, Sio FRSD, Rudilosso L, Gallina P, Calabria A, Beretta S, Merelli I, Bruzzesi E, Passerini L, Nozza S, Vicenzi E, Poli G, Gregori S, Tambussi G, Montini E. HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells.Nat Comm. 2017;8(1):498. doi: 10.1038/s41467-017-00609-1. PMID: 28887441; PMCID: PMC5591266.
59. Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB. Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology. 1999;257(2):502-10. doi: 10.1006/viro.1999.9688. PMID: 10329560.
60. Zheng L, Yang Y, Guocai L, Pauza CD, Salvato MS. HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand. Intervirology. 2007;50(3):224-228. doi: 10.1159/000100565. PMID: 17356300; PMCID: PMC2384232.
61. López CS, Sloan R, Cylinder I, Kozak SL, Kabat D, Barklis E. RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release. Virology. 2014;462-463:126-34.. doi: 10.1016/j.virol.2014.05.019. PMID: 24971705; PMCID: PMC4125522.
62. Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O’Doherty U, Paxinos EE, Fauci AS, Lane HC. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A. 2016;113(31):8783-8. doi: 10.1073/pnas.1609057113. PMID: 27432972; PMCID: PMC4978246.
63. Kutluay SB, Zang T, Blanco-Melo D, Powell C, Jannain D, Errando M, Bieniasz PD. Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis. Cell. 2014;159(5):1096-1109. doi: 10.1016/j.cell.2014.09.057. PMID: 25416948; PMCID: PMC4247003.
64. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998;391(6665):397-401. doi: 10.1038/34929. PMID: 9450757.
65. Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996;2(3):338-344. doi: 10.1038/nm0396-338. PMID: 8612235.
66. Einkauf KB, Osborn MR, Gao C, Sun W, Sun X, Lian X, Parsons EM, Gladkov GT, Seiger KW, Blackmer JE, Jiang C, Yukl SA, Rosenberg ES, Yu XG, Lichterfeld M. Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses. Cell. 2022;185(2):266-282.e15. doi: 10.1016/j.cell.2021.12.011. PMID: 35026153; PMCID: PMC8809251.
67. Lian X, Gao C, Sun X, Jiang C, Einkauf KB, Seiger KW, Chevalier JM, Yuki Y, Martin M, Hoh R, Peluso MJ, Carrington M, Ruiz-Mateos E, Deeks SG, Rosenberg ES, Walker BD, Lichterfeld M, Yu XG. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers. Sci Transl Med. 2021;13(624):eabl4097. doi: 10.1126/scitranslmed.abl4097. PMID: 34910552; PMCID: PMC9202005.
68. Jiang C, Lian X, Gao C, Sun X, Einkauf KB, Chevalier JM, Chen SMY, Hua S, Rhee B, Chang K, Blackmer JE, Osborn M, Peluso MJ, Hoh R, Somsouk M, Milush J, Bertagnolli LN, Sweet SE, Varriale JA, Burbelo PD, Chun TW, Laird GM, Serrao E, Engelman AN, Carrington M, Siliciano RF, Siliciano JM, Deeks SG, Walker BD, Lichterfeld M, Yu XG. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature. 2020;585(7824):261-267. doi: 10.1038/s41586-020-2651-8. PMID: 32848246; PMCID: PMC7837306.